Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by jammer4444on Jul 24, 2017 3:31pm
69 Views
Post# 26502706

RE:RE:RE:Here's what I'm reading

RE:RE:RE:Here's what I'm readingYou worry about making sense, and I will worry about making millions of dollars.

Alanmakingcents wrote: And YOU are very wrong in saying at 5 million in sales the company is profitable. Just because the company lost 3 million on 2 million of sales doesn't imply that if they increase sales by 3 million they suddenly break even. Talk about stretching reality! They just announced hiring more PHDs. Are they working for free? There is a reason they are borrowing at 10% plus incentive warrants that the company says is an effective rate of over 20% per annum. Does that sound like a company with profitability around the corner. And why if this past contract provides over 5 million dollars each and every year, is the CEO only forecasting 6 million for the whole year from all past and future deals?

This company has potential but it is trading at .14 because today it is worth .14. To some. Personally I think it is overvalued. I'm looking to buy down the road if I see more clarity.

Alan


Bullboard Posts